The essential role of the in situ immune reaction in human colorectal cancer
- 17 June 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (4), 981-987
- https://doi.org/10.1189/jlb.1107773
Abstract
Colorectal cancer is the second most common cause of cancer-related death. Novel prognostic factors should be identified and validated to refine the present tumor-node-metastasis system. The presence of immune cells infiltrating colorectal cancers is a common phenomenon. However, the current belief is that clinically detectable human tumors escaping immune surveillance are no longer kept in check by the immune cells of the tumor microenvironment. Despite studies showing the influence of immune cell infiltrates on the behavior of colorectal carcinomas, this parameter is not currently recognized as a reliable prognostic factor. We showed that the nature, functional orientation, density, and location of immune cells within distinct tumor regions could provide a prognostic factor superior to and independent of criteria related to the anatomic extent of the tumor. The strength of the immune reaction identified in our studies could advance our understanding of cancer evolution and have important consequences for clinical practice.Keywords
This publication has 42 references indexed in Scilit:
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Gene-Expression Profiling Predicts Recurrence in Dukes’ C Colorectal CancerGastroenterology, 2005
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Molecular Staging for Survival Prediction of Colorectal Cancer PatientsJournal of Clinical Oncology, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Inflammation and cancerNature, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Detection and clinical significance of occult tumour cells in colorectal cancerBritish Journal of Surgery, 2001
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989